Listed

Eikon Therapeutics, Inc.

EIKNNasdaqCIK 1861123HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$93.4m, Q2 FY2026
Net income−$88.4m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m56.6Research and development, period not labelled, three months to 2025-03-31$56.6m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure69.2Research and development, period not labelled, three months to 2025-06-30$69.2m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure70.0Research and development, Q1 FY2026, three months to 2026-03-31$70.0m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure75.5Research and development, Q2 FY2026, three months to 2026-06-30$75.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure
Operating income$m(71.4)Operating income, period not labelled, three months to 2025-03-31−$71.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure(110)Operating income, period not labelled, three months to 2025-06-30−$109.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure(87.3)Operating income, Q1 FY2026, three months to 2026-03-31−$87.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure(93.4)Operating income, Q2 FY2026, three months to 2026-06-30−$93.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure
Net income$m(68.2)Net income, period not labelled, three months to 2025-03-31−$68.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure(105)Net income, period not labelled, three months to 2025-06-30−$105.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure(83.0)Net income, Q1 FY2026, three months to 2026-03-31−$83.0m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure(88.4)Net income, Q2 FY2026, three months to 2026-06-30−$88.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure
Diluted EPS$ per share(26.91)Diluted EPS, period not labelled, three months to 2025-03-31−$26.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure(36.94)Diluted EPS, period not labelled, three months to 2025-06-30−$36.94 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure(2.46)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$2.46 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure(1.63)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$1.63 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure
Basic EPS$ per share(26.91)Basic EPS, period not labelled, three months to 2025-03-31−$26.91 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure(36.94)Basic EPS, period not labelled, three months to 2025-06-30−$36.94 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure(2.46)Basic EPS, Q1 FY2026, three months to 2026-03-31−$2.46 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure(1.63)Basic EPS, Q2 FY2026, three months to 2026-06-30−$1.63 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure

Balance sheet

Cash and equivalents$142.6m, Q2 FY2026
Shareholders' equity$466.5m, Q2 FY2026
Line itemUnitperiod not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30period not labelled2025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported205Cash and equivalents, period not labelled, at 2025-03-31$204.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure137Cash and equivalents, period not labelled, at 2025-06-30$136.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure105Cash and equivalents, period not labelled, at 2025-12-31$104.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure161Cash and equivalents, Q1 FY2026, at 2026-03-31$161.2m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure143Cash and equivalents, Q2 FY2026, at 2026-06-30$142.6m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure
Current assets$mnot reportednot reportednot reported349Current assets, period not labelled, at 2025-12-31$348.9m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure530Current assets, Q1 FY2026, at 2026-03-31$529.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure547Current assets, Q2 FY2026, at 2026-06-30$547.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure
Total assets$mnot reportednot reportednot reported595Total assets, period not labelled, at 2025-12-31$594.7m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure851Total assets, Q1 FY2026, at 2026-03-31$850.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure780Total assets, Q2 FY2026, at 2026-06-30$779.6m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure
Current liabilities$mnot reportednot reportednot reported55.0Current liabilities, period not labelled, at 2025-12-31$55.0m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure45.1Current liabilities, Q1 FY2026, at 2026-03-31$45.1m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure55.3Current liabilities, Q2 FY2026, at 2026-06-30$55.3m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure
Total liabilities$mnot reportednot reportednot reported312Total liabilities, period not labelled, at 2025-12-31$312.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure300Total liabilities, Q1 FY2026, at 2026-03-31$300.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure313Total liabilities, Q2 FY2026, at 2026-06-30$313.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure
Shareholders' equity$m(572)Shareholders' equity, period not labelled, at 2024-12-31−$571.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure(640)Shareholders' equity, period not labelled, at 2025-03-31−$640.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure(738)Shareholders' equity, period not labelled, at 2025-06-30−$737.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure(879)Shareholders' equity, period not labelled, at 2025-12-31−$879.0m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure551Shareholders' equity, Q1 FY2026, at 2026-03-31$550.7m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure467Shareholders' equity, Q2 FY2026, at 2026-06-30$466.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure

Cash flow

Operating cash flow−$65.0m, Q2 FY2026
Capital expenditure$251.0k, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(54.5)Operating cash flow, period not labelled, three months to 2025-03-31−$54.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure(32.7)Operating cash flow, period not labelled, three months to 2025-06-30−$32.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349185. Derived: 6-month figure less the 3-month figure.Report this figure(89.8)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$89.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure(65.0)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$65.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-13, accession 0001193125-26-349185. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m22.4Capital expenditure, period not labelled, three months to 2025-03-31$22.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure21.7Capital expenditure, period not labelled, three months to 2025-06-30$21.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349185. Derived: 6-month figure less the 3-month figure.Report this figure0.3Capital expenditure, Q1 FY2026, three months to 2026-03-31$262.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure0.3Capital expenditure, Q2 FY2026, three months to 2026-06-30$251.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-13, accession 0001193125-26-349185. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)54.14m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares2.8Diluted shares (weighted), period not labelled, three months to 2025-03-312,770,352 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure2.8Diluted shares (weighted), period not labelled, three months to 2025-06-302,848,529 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure33.7Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3133,700,550 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-11, accession 0001193125-26-216791.Report this figure54.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3054,143,162 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure

Shares outstanding: 54.17mShares outstanding, period not labelled, at 2026-08-0354,165,030 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-13, accession 0001193125-26-349185.Report this figure at Aug 3, 2026, from the cover of the 10-Q filed Aug 13, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.